Research of oncomiRs contributing to initiation process of inflammation-associated carcinogenesis in liver
Project/Area Number |
19390198
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Gastroenterology
|
Research Institution | Kanazawa University |
Principal Investigator |
NAKAMOTO Yasunari Kanazawa University, 附属病院, 講師 (40293352)
|
Co-Investigator(Kenkyū-buntansha) |
HIRAKU Yusuke 三重大学, 医学系研究科, 講師 (30324510)
|
Project Period (FY) |
2007 – 2009
|
Project Status |
Completed (Fiscal Year 2009)
|
Budget Amount *help |
¥14,690,000 (Direct Cost: ¥11,300,000、Indirect Cost: ¥3,390,000)
Fiscal Year 2009: ¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2008: ¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2007: ¥6,110,000 (Direct Cost: ¥4,700,000、Indirect Cost: ¥1,410,000)
|
Keywords | 癌 / 遺伝子 / マイクロアレイ / 動物 / 内科 |
Research Abstract |
慢性肝炎から肝がんに至るがん化のイニシエーション過程に作用するマイクロRNA分子[oncogenic micro RNA ; oncomiR(s)]を同定することを目的とした。これまで確立したB型肝炎ウイルス(HBV)トランスジェニックマウスを用いた炎症性発がんモデルにおいて、経時的な遺伝子発現および酸化ストレスと相関する8個のoncomiR分子を明らかにした。これらの分子は、肝臓における前がん状態で悪性転化を制御する標的となる可能性が示唆された。
|
Report
(4 results)
Research Products
(40 results)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Journal Article] Combined therapy of transcatheter hepatic arterial embolization with intratumoral dendritic cell infusion for hepatocellular carcinoma2007
Author(s)
Nakamoto Y, Mizukoshi E, Tsuji H, Sakai Y, Kitahara M, Arai K, Yamashita T, Yokoyama K, Mukaida N, Matsushima K, Matsui O, Kaneko S
-
Journal Title
clinical safety. Clin. Exp. Immunol. 251
Pages: 36-42
Related Report
Peer Reviewed
-
-
-
-
[Journal Article] Impact of diabetes on recurrence of hepatocellular carcinoma after surgical treatment in patients with viral hepatitis2007
Author(s)
Komura T, Mizukoshi E, Kita Y, Sakurai M, Takata Y, Arai K, Yamashita T, Ohta T, Shimizu K, Nakamoto Y, Honda M, Takamura T, Kaneko S
-
Journal Title
Am. J. Gastroenterol. 102
Pages: 1939-1946
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
[Presentation] #1725; Immunological factors associated with prolonged recurrence-free survival following transcatheter hepatic arterial embolization with OK432-stimulated dendritic cell transfer into hepatocellular carcinoma.2009
Author(s)
Nakamoto Y, Mizukoshi E, Kitahara M, Arihara F, Sakai Y, Kakinoki K, Fujita Y, Marukawa Y, Arai K, Yamashita T, Mukaida N, Matsushima K, Matsui O, Kaneko S
Organizer
第60回American Association for the Study of Liver Diseases (AASLD) Annual Meeting (Boston, Massachusetts)
Place of Presentation
Hepatology
Year and Date
2009-11-03
Related Report
-
-
-
[Presentation] 125; Prolonged recurrence-free survival following combined therapy of transcatheter hepatic arterial embolization with OK432-stimulated dendritic cell transfer into hepatocellular carcinoma.2008
Author(s)
Nakamoto Y, Mizukoshi E, Kitahara M, Sakai Y, Kakinoki K, Fujita Y, Arai K, Yamashita T, Mukaida N, Matsushima K, Matsui O, Kaneko S
Organizer
第59回American Association for the Study of Liver Diseases (AASLD) Annual Meeting (San Francisco, California)
Place of Presentation
Hepatology
Year and Date
2008-11-02
Related Report
-
-
-
-
-
-
-
-
-
-